Date25 November 2011

Ms KateWalker

email:

DearKate

Thank you for your request for information about Type 2 Diabetes. Your request was received on 22 November 2011 and I am dealing with it under the terms of the Freedom of Information Act 2000.

Your request is being considered and you will receive the information requested within the statutory timescale of 20 working days as defined by the Freedom of Information Act 2000, subject to the information not being exempt or containing a reference to a third party.

If appropriate, the information may be provided in paper copy, normal font size. If you require alternative formats, e.g. language, audio, large print, etc. then please let me know.

For your information, the Act defines a number of exemptions which may prevent release of the information you have requested. You will be informed if this is the case, including your rights of appeal.

In some circumstances a fee may be payable and if that is the case, I will let you know. A fees notice will be issued to you, and you will be required to pay before we will proceed to deal with your request.

If you have any queries about this letter, please contact me. Please remember to quote the reference number above in any future communications.

Further information about your rights is also available from the InformationCommissioner at: Information Commissioner's Office

Wycliffe House

Water Lane

Wilmslow

Cheshire, SK9 5AF

Telephone: 01625 545 700

Re-Use of Information

Any information we provide following your request under the Freedom of Information Act will not confer an automatic right for you to re-use that information, for example to publish it. If you wish to re-use the information that we provide and you do not specify this in your initial application for information then you must make a further request for its re-use as per the Re-Use of Public Sector Information Regulations 2005 . This will not affect your initial information request.

Yours sincerely

Anna Lewandowska

Information Governance Officer

Chair: Angela Monaghan

Chief Executive: Mike Potts

Clinical Commissioning Executive Chair: Dr Alan Brook